Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017033208) IMPLANTABLE NALTREXONE TABLETS
Available information on National Phase entries(more information)
OfficeEntry DateNational NumberNational Status
Canada 30.01.20182994212
United States of America 02.05.201815755374Published: 29.11.2018
European Patent Office (EPO)2016838697Published: 04.07.2018